AOD-9604 accelerates fat loss. The scientific gap There are no high-quality randomized trials demonstrating that semaglutide + AOD-9604 produces better outcomes than semaglutide alone, or that it improves lean mass retention, resting metabolic rate, or long-term weight maintenance
PMID: 38440786
It also acts as a skin-lightening agent by inhibiting melanin production, ensuring a smoother and more youthful complexion
Originally FDA-approved for HIV-associated lipodystrophy, Tesamorelin has powerful benefits for midsection fat reduction, cognitive health, and body composition in the general population
These participants were randomized to once-weekly subcutaneous retatrutide (1, 4, 8, or 12 mg) or placebo for 48 weeks
Origins of cystic fibrosis lung disease